Just intrigued by the move today and into post market.
Flex Pharma, Inc. (FLKS)
Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with the proposed sale of FLKS to Salarius Pharmaceuticals, LLC.
If you are a FLKS investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.